These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 39295180)
21. A combined intrapleural administration of dornase alfa and tissue plasminogen activator is safe in children with empyema - A pilot study. Slaats MA; De Dooy J; Van Hoorenbeeck K; Van Schil PEY; Verhulst SL; Hendriks JMH Acta Chir Belg; 2021 Jun; 121(3):184-188. PubMed ID: 31750793 [TBL] [Abstract][Full Text] [Related]
22. Intrapleural Fibrinolytic Therapy versus Early Medical Thoracoscopy for Treatment of Pleural Infection. Randomized Controlled Clinical Trial. Kheir F; Thakore S; Mehta H; Jantz M; Parikh M; Chee A; Kaphle U; Sisnega C; Fernandez-Bussy S; Majid A Ann Am Thorac Soc; 2020 Aug; 17(8):958-964. PubMed ID: 32421353 [No Abstract] [Full Text] [Related]
23. Therapy of 645 children with parapneumonic effusion and empyema-A German nationwide surveillance study. Segerer FJ; Seeger K; Maier A; Hagemann C; Schoen C; van der Linden M; Streng A; Rose MA; Liese JG Pediatr Pulmonol; 2017 Apr; 52(4):540-547. PubMed ID: 27648553 [TBL] [Abstract][Full Text] [Related]
24. Intrapleural streptokinase treatment in children with empyema. Aydoğan M; Aydoğan A; Ozcan A; Tugay M; Gokalp AS; Arisoy ES Eur J Pediatr; 2008 Jul; 167(7):739-44. PubMed ID: 17710434 [TBL] [Abstract][Full Text] [Related]
25. Predictive Variables for Failure in Administration of Intrapleural Tissue Plasminogen Activator/Deoxyribonuclease in Patients With Complicated Parapneumonic Effusions/Empyema. Khemasuwan D; Sorensen J; Griffin DC Chest; 2018 Sep; 154(3):550-556. PubMed ID: 29425674 [TBL] [Abstract][Full Text] [Related]
27. Alteplase Dose Assessment for Pleural infection Therapy (ADAPT) Study-2: Use of 2.5 mg alteplase as a starting intrapleural dose. Popowicz N; Ip H; Lau EPM; Piccolo F; Dootson K; Yeoh C; Phu WY; Brown R; West A; Ahmed L; Lee YCG Respirology; 2022 Jul; 27(7):510-516. PubMed ID: 35441458 [TBL] [Abstract][Full Text] [Related]
28. Can intrapleural alteplase treatment be an alternative to videothoracoscopic deloculation and decortication in pleural empyema? Kermenli T; Azar C Wideochir Inne Tech Maloinwazyjne; 2021 Sep; 16(3):580-586. PubMed ID: 34691309 [TBL] [Abstract][Full Text] [Related]
29. Treatment of complicated parapneumonic pleural effusion with intrapleural streptokinase in children. Yao CT; Wu JM; Liu CC; Wu MH; Chuang HY; Wang JN Chest; 2004 Feb; 125(2):566-71. PubMed ID: 14769739 [TBL] [Abstract][Full Text] [Related]
30. Stratifying fibrinolytic dosing in pediatric parapneumonic effusion based on ultrasound grade correlation. James CA; Braswell LE; Pezeshkmehr AH; Roberson PK; Parks JA; Moore MB Pediatr Radiol; 2017 Jan; 47(1):89-95. PubMed ID: 27709281 [TBL] [Abstract][Full Text] [Related]
31. Efficacy of intrapleural instillation of fibrinolytics for treating pleural empyema and parapneumonic effusion: a meta-analysis of randomized control trials. Nie W; Liu Y; Ye J; Shi L; Shao F; Ying K; Zhang R Clin Respir J; 2014 Jul; 8(3):281-91. PubMed ID: 24428897 [TBL] [Abstract][Full Text] [Related]
32. Intrapleural alteplase therapy: what are the knowns and unknowns? Staša J; Gregorová J; Pauk N Cas Lek Cesk; 2019; 158(7-8):295-299. PubMed ID: 31995996 [TBL] [Abstract][Full Text] [Related]
33. [Intrapleural streptokinase in the treatment of complicated parapneumonic empyema]. Fernández Fernández A; Giachetto Larraz G; Giannini Fernández G; Garat Gómez MC; Vero Acevedo MA; Pastorini Correa J; Castillo Casati C; Pírez García MC; Servente Luquetti L; Ferrari Castilla AM An Pediatr (Barc); 2007 Jun; 66(6):585-90. PubMed ID: 17583620 [TBL] [Abstract][Full Text] [Related]
35. Safety and Efficacy of Intrapleural Tissue Plasminogen Activator and DNase during Extended Use in Complicated Pleural Space Infections. McClune JR; Wilshire CL; Gorden JA; Louie BE; Farviar AS; Stefanski MJ; Vallieres E; Aye RW; Gilbert CR Can Respir J; 2016; 2016():9796768. PubMed ID: 27445574 [TBL] [Abstract][Full Text] [Related]
36. Alteplase and DNase for the treatment of pleural empyema in rats. Gehlen M; Fraga JC; Amantea SL; Silveira NP; Kulczynski J; Roesch E; Portal KG; Sanches PR Pulm Pharmacol Ther; 2019 Apr; 55():1-4. PubMed ID: 30648619 [TBL] [Abstract][Full Text] [Related]
37. Management of Intrapleural Sepsis with Once Daily Use of Tissue Plasminogen Activator and Deoxyribonuclease. Mehta HJ; Biswas A; Penley AM; Cope J; Barnes M; Jantz MA Respiration; 2016; 91(2):101-6. PubMed ID: 26761711 [TBL] [Abstract][Full Text] [Related]
38. Benefit of intrapleural fibrinolytic therapy in the treatment of complicated parapneumonic effusion and empyema. Merhabene T; Zayet S; Jamoussi A; Ayed S; Mansouri S; Khelil JB; Besbes M Pan Afr Med J; 2024; 47():54. PubMed ID: 38646137 [TBL] [Abstract][Full Text] [Related]
39. Tissue plasminogen activator for the treatment of parapneumonic effusions in pediatric patients. Israel EN; Blackmer AB Pharmacotherapy; 2014 May; 34(5):521-32. PubMed ID: 24390857 [TBL] [Abstract][Full Text] [Related]